Fusobacterium is a genus of obligate anaerobic, Gram-negative, [2] non-sporeforming bacteria [3] belonging to Gracilicutes. Individual cells are slender, rod-shaped bacilli with pointed ends. [4][5] Fusobacterium was discovered in 1900 by Courmont and Cade and …

Fusobacterium organisms are anaerobic, gram-negative bacilli that are similar to certain Bacteroides spp. They appear as spindle-shaped cells with sharp ends. Both reside in the gut but are capable of causing serious infection.

Fusobacteriota are obligately anaerobic non-sporeforming Gram-negative bacilli. Since the first reports in the late nineteenth century, various names have been applied to these organisms, sometimes with the same name being applied to different species.

Fusobacteria are anaerobic gram-negative rods that are a rare cause of serious human disease [1, 2]. Two Fusobacterium species, F. nucleatum and F. necrophorum, are the most commonly isolated pathogens within this genus [2, 3].

Jan 1, 2020 · In this chapter, we attempt to summarize the main physiological, phylogenetic, and genotypic attributes of the Fusobacteria, with special emphasis on F. nucleatum. Fusobacteria are an enigmatic group of bacterial species.

This review outlines the influence of Fusobacteria in promoting cancer initiation and progression, impacts of therapeutic outcomes and discusses potential therapeutic interventions where appropriate.

Jun 10, 2024 · Fusobacterium spp. are sensitive to colistin and kanamycin, distinguishing them from Bacteroides and Porphyromonas. Produces significant LPS, which may account for virulence. Historically thought to be part of normal human flora; some, especially for F. nucleatum, believe it is more likely a pathogen if recovered.

Fusobacteria is a phylum under the domain Bacteria. It consists of the families Fusobacteriaceae and Leptotrichiaceae and several genera. Read more.

Fusobacterium species are obligately anaerobic, gram-negative bacilli. Especially, F. nucleatum and F. necrophorum are highly relevant human pathogens. We investigated clinical differences in patients infected with Fusobacterium spp. and determined the antimicrobial susceptibility of Fusobacterium isolates.

The involvement of fusobacteria in a wide spectrum of human infections causing tissue necrosis and septicaemia has long been recognised, and, more recently, their importance in intra-amniotic infections, premature labour and tropical ulcers has been reported.